You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Cytokeratin 8 antibody [M20] (ab9023)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Cytokeratin 8 antibody [M20]
See all Cytokeratin 8 products (34) ...

Description

Mouse monoclonal [M20] to Cytokeratin 8

Specificity

Reacts with glandular epithelial cells (endocrine and exocrine) as well as mesothelial cells of the digestive, respiratory and urogenital tract and most adenocarcinomas derived from these cells.

Tested applications

Flow Cyt, IHC-P, ICC, IHC-Fr, WB, ICC/IFmore details

Cross reactivity

Reacts with

Human

Immunogen

Keratin isolated from the human breast carcinoma cell line MCF-7.

Positive control

Human colon for IHC-Fr

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

Preservative: 0.09% Sodium Azide
Constituents: PBS

Concentration

Concentration information loading...

Purity

Protein G purified

Primary antibody notes

Cytokeratins are a subfamily of intermediate filament proteins and are characterized by a remarkable biochemical diversity, represented in epithelial tissues by at least 20 different polypeptides. They range in molecular weight between 40 kDa and 68 kDa and isoelectric pH between 4.9 – 7.8. The individual cytokeratin polypeptides are numbered 1 to 20. The various epithelia in the human body usually express cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of maturation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays.

Clonality

Monoclonal

Clone number

M20

Isotype

IgG1

  • Western blot - Cytokeratin 8 antibody [M20] (ab9023)Western blot - Cytokeratin 8 antibody [M20] (ab9023) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab9023 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.

Tissue specificity

Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma membrane in structures that contain dystrophin and spectrin. Expressed in gingival mucosa and hard palate of the oral cavity.

Involvement in disease

Defects in KRT8 are a cause of cirrhosis (CIRRH) [MIM:215600].

Sequence similarities

Belongs to the intermediate filament family.

Post-translational
modifications

Phosphorylation on serine residues is enhanced during EGF stimulation and mitosis. Ser-74 phosphorylation plays an important role in keratin filament reorganization.
O-glycosylated at multiple sites; glycans consist of single N-acetylglucosamine residues.

Cellular localization

Cytoplasm. Nucleus > nucleoplasm. Nucleus matrix.

Target information above from: UniProt accessionP05787 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • card2 antibody
  • Cardiac autoantigen 2 120kD antibody
  • CK 8 antibody
  • CK-8 antibody
  • ck8 antibody
  • Cyk 8 antibody
  • cyk8 antibody
  • CYKER antibody
  • Cytokeratin 8 antibody
  • Cytokeratin endo A antibody
  • Cytokeratin-8 antibody
  • Cytokeratin8 antibody
  • DreK8 antibody
  • EndoA antibody
  • k0 antibody
  • k2c8 antibody
  • K2C8_HUMAN antibody
  • k8 antibody
  • Keratin 8 antibody
  • Keratin type ii cytoskeletal 8 antibody
  • Keratin, type II cytoskeletal 8 antibody
  • Keratin-8 antibody
  • Keratin8 antibody
  • KO antibody
  • Krt 2.8 antibody
  • Krt 8 antibody
  • krt8 antibody
  • MGC118110 antibody
  • MGC174782 antibody
  • MGC53564 antibody
  • MGC85764 antibody
  • sb:cb186 antibody
  • Type-II keratin Kb8 antibody
see all

Anti-Cytokeratin 8 antibody [M20] images:

  Western blot - Cytokeratin 8 antibody [M20] (ab9023)

Western blot - Cytokeratin 8 antibody [M20] (ab9023)

The image shows different concentration of total protein from normal and tumour colon tissues.

This picture was kindly supplied as part of the review submitted by Semona Rupchand.

  Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)

Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)

ab9023 staining MCF-7 breast cancer cells, grown in 8 well chamber slides, by ICC/IF.  Cells were fixed with Acetone for 20 minutes at -20°C and permabilized with 0.1% Triton X-100 for 5 minutes at 4°C prior to blocking in 1% fish gelatin for 1 hour at RT.  The primary antibody was diluted 1/100 and incubated with the sample for 1 hour.  An Alexa Fluor® 488 conjugated donkey anti-mouse antibody diluted 1/1000 was used as the secondary.  Slides were mounted using mounting medium containing DAPI.

This image is courtesy of an anonymous Abreview

See Abreview

  Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)

Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)

Ab9023 staining cells from a human pancreatic cancer cell line by ICC/IF.  The cells were PFA fixed and permeabilized in 0.1% Triton X-100 prior to blocking in 1% BSA for 30 minutes at 22°C.  Ab9023 was diluted 1/100 and incubated with the sample for 1 hour at 22°C.  An Alexa Fluor® 488 conjugated donkey anti-mouse antibody, diluted 1/1000, was used as the secondary.

This image is courtesy of an Abreview submitted by Dr Hannah Whiteman

See Abreview

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 8 antibody [M20] (ab9023)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 8 antibody [M20] (ab9023)

Ab9023 staining human normal liver parenchima tissue. Staining is localized to cell membrane.
Left panel: with primary antibody at 4 ug/ml. Right panel: isotype control.
Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

  Western blot - Cytokeratin 8 antibody [M20] (ab9023)

Western blot - Cytokeratin 8 antibody [M20] (ab9023)

All lanes : Anti-Cytokeratin 8 antibody [M20] (ab9023) at 1/2000 dilution

Lane 1 : Lysate prepared from human prostate cancer LNCaP cells
Lane 2 : Lysate prepared from human prostate cancer PC3 cells

Lysates/proteins at 50 µg per lane.

Secondary
HRP-conjugated goat polyclonal to mouse IgG at 1/10000 dilution
developed using the ECL technique

Performed under reducing conditions.

Observed band size : 50 kDa (why is the actual band size different from the predicted?)
Additional bands at : 26 kDa,65 kDa. We are unsure as to the identity of these extra bands.

Exposure time : 4 minutes

This image is a courtesy of Anonymous Abreview

See Abreview

  Flow Cytometry - Cytokeratin 8 antibody [M20] (ab9023)

Flow Cytometry - Cytokeratin 8 antibody [M20] (ab9023)

Overlay histogram showing MCF-7 cells stained with ab9023 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.5% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab9023, 2µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H&L) (ab96879) at 1/250 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in MCF-7 cells fixed with methanol (5 min)/permeabilized in 0.5% PBS-Tween used under the same conditions.

  Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)

Immunocytochemistry/ Immunofluorescence - Cytokeratin 8 antibody [M20] (ab9023)

ab9023 staining Cytokeratin 8 in human epithelial ovarian cancer (EOC) cell line OV-MZ-6 by Immunocytochemistry/ Immunofluorescence.

Samples were fixed with 4% PFA in PBS pH 7.4 and then permeabilised using 0.2% saponin for 30 minutes. A blocking step was performed using 1% BSA/PBS for 1 hour. Samples were then incubated with ab9023 at a 1/100 dilution in 1% BSA/PBS for 1 hour. The secondary antibody was a goat anti-mouse Alexa 488 (green) diluted 1/1000, 1% BSA/PBS for 1 hour. Samples were then incubated with phalloidin (red for actin staining) in 1% BSA/PBS for 45 minutes and counterstained with DAPI (blue for nuclei staining) in PBS for 45 minutes.

Image from Loessner D et al, Biomaterials. 2010 Nov;31(32):8494-506. Epub 2010 Aug 14. doi:10.1016/j.biomaterials.2010.07.064

References for Anti-Cytokeratin 8 antibody [M20] (ab9023)

This product has been referenced in:

  • Whiteman HJet al. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 67:8633-42 (2007).Read more (PubMed: 17875703) »
  • Khan AQet al. Keratin 8 expression in colon cancer associates with low faecal butyrate levels. BMC Gastroenterol 11:2 (2011). IHC-P; Human.Read more (PubMed: 21219647) »

See all 7 publications for this product

Publishing research using ab9023? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"